TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Physical activity engagement in pregnant women
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dental plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of cardiac death, myocardial infarction, and target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: need for target vessel revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: walking competency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spatio-temporal gait parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completed registration of PAPPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients requiring rescue antiemetics
Endpoint domain: Adverse events/effects
Primary endpoint: Mean maternal weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of a new birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Effect of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of analgesia and sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma markers of systemic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: venous attenuation of the IJV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Current contraceptive use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of contraceptives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Method-specific discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective ratings of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Running velocity at low intensities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in morning SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of IVIg and PLEX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients improved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time needed to achieve OPS score <= 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of fentanyl used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dizziness rate
Endpoint domain: Adverse events/effects
Primary endpoint: Prevention of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of atypia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe disposal of child faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale score pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative respiratory complications
Endpoint domain: Adverse events/effects
Primary endpoint: Fractional decrement in tacrine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of postpericardiotomy syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CK‐MB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HSP‐72‐protein expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peak expiratory flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: catheter colonization rate
Endpoint domain: Adverse events/effects
Primary endpoint: CR-BSI rate
Endpoint domain: Adverse events/effects
Primary endpoint: MFIQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plate removal due to complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time to shift to Kangaroo ward
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction of hospital and parents expenditure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in urinary incontinence episodes per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Subjective perception of improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of transfusions administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Absolute reticulocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: percentage of joints with lasting remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monthly pictorial blood loss-assessment chart scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: successful use of PCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of failure of PCS
Endpoint domain: Adverse events/effects
Primary endpoint: cardiorespiratory adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: fear of hypoglycemia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PCT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Life (QOL) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of obstructive and irritative nature of LUTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival abrasion scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of events in the NT-proBNP arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global seropositivity of antibodies against Hp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the blood concentration time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Systolic blood pressure trend
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery time (time of eye opening)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in non-HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attainment of LDL-C and non-HDL-C targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of viremia clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to sustained absence of heartburn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: percentage of time for which intragastric pH was greater than 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain and fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Portal venous flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subhepatic inferior vena caval flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of death from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Improvements in suicidal ideation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weight decrease (≥3.5%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sheehan disability scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Global quality of life rating improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: survival without BPD
Endpoint domain: Mortality/survival
Primary endpoint: Hemoglobin concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Anemia prevalence decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum ferritin concentration increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Recovery of prefracture physical functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion for ankle extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular strength on adduction and abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum uric acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Partial or full response to posterior tibial nerve stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of wet nights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-minute VAS reduction in nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone Mineral Density (BMD) at lumbar spine and femoral neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of blood pressures in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: perceived improvement in back status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean LDL-C changes from baseline to Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Achievement of risk-based LDL-C goals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment-emergent adverse event rates
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant gastrointestinal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Infective ventilator‐associated complication or pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clostridium difficile infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mean increase in thumb web-space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythrocyte folate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma tHcy concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: milk transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breastfeeding duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Non-adherence to treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surfactant protein D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Angiopoietin-2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Von Willebrand factor antigen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Sensitivity for acute ischemia monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity for acute ischemia monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FLO-7 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: age of appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median area under the plasma celiprolol concentration-time curve (AUC(0-33 h))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median amount of celiprolol excreted into urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Celiprolol renal clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: sputum volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ipsilateral hemispheric stroke recurrence
Endpoint domain: Mortality/survival
Primary endpoint: KIR2DL1 HLA-C2 combination frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Induced corneal edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' perception of bladder condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Upper extremity functional capacity goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of patients achieving 10 mm or more Schirmer wetting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neointima volume per mm of stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Fraction of unbound propofol in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial plasma glucose (PPPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of HbA1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite outcome occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Severe hypoglycemia occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of IRF (Intraoperative Fracture)
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of endoscopist's prediction of celiac sprue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platelet membrane fluidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost per counselling episode
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: faster mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: subjective total sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of questionnaires returned
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of questionnaires returned without chasing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall non‐response rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health rating as fair or poor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of loose or watery stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Orocaecal and whole gut transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disability (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time in target glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean glycated hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Successful penile insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Time to admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GBS colonization at the time of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Torsional stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy absorption during axial loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of causal nature of side effects
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Progression to prostate cancer (PCa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Esophageal temperature inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma catecholamine concentrations inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hydrolysis of PSTE and PSTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Excretion of fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: correct inference of HII position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevented or incomplete re-inflation of the bulb
Endpoint domain: Adverse events/effects
Primary endpoint: Pulsus paradoxus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: reduced perceived noise level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported HIV testing in the past 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of PSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: TGF-ß2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extubation delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial pressure values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean clinical systolic BP (SBP)/diastolic BP (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of treated biopsy-proven acute rejection
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of trunk fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Probability of transition to a nursing home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Cosmetic results
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perioperative toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Acute skin toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Composite endpoint of death, MI, and bleeding at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: safety and effectiveness of wireless CRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-peptidogenic index (ΔCP30/ΔG30)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: SVG occlusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: intimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Life expectancy gain for all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Life expectancy gain for cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Survival free from cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Erection sufficient for sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients attaining at least 75% of erections sufficient for sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BACS score for attention and processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of acute postoperative pain
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate filling of root canals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at first follow-up appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attendance at four or more treatment sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: triglyceride (TG) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of clinically significant prostate cancer
Endpoint domain: Mortality/survival